BMSN Stock DD Bio-Matrix Scientific Group, Inc. Saturday, June

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
BMSN Bio-Matrix Scientific Group, Inc. $BMSN Company Overview

Stock Message Board http://investorshangout.com/search?q=BMSN&...mp;yt1=Go!

Last Updated: Saturday, June 21, 2014 7:39:21 PM

Bio-Matrix Scientific Group, Inc. BMSN Current Price and Quotes
Last Price 0.0033
Previous Close 0.0035 Open 0.0034
Daily Range 0.0032 - 0.0034 52wk Range 0.0011 - 0.0091
Volume 16,743,147 Dividend N/A
Average Vol (3m) 21,364,180 Yield N/A
Bio-Matrix Scientific Group, Inc. BMSN

Bio-Matrix Scientific Group, Inc. BMSN
Bio-Matrix Scientific Group, Inc. BMSN

Bio-Matrix Scientific Group, Inc. BMSN


Bio-Matrix Scientific Group, Inc. BMSN Financials
Period Ending Sep 30, 2013 Sep 30, 2012 Sep 30, 2011 Sep 30, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development 10 18 51 417
Sales, General and Admin. 1,518 778 843 1,251
Non-Recurring Items - - - -
Other - - - -
Operating Income (1,528) (795) (894) (1,667)
Income From Continuing Operations

Add'l Income/Expense Items 25 (129) 41,282 -
Earnings Before Interest and Tax (1,503) (924) 40,387 (1,667)
Interest Expense 502 429 63 91
Earnings Before Tax (2,005) (1,354) 40,324 (1,759)
Income Tax - - - -
Minority Interest (9) - (230) (213)
Equity Earnings Unconsolidated Subsidiary - (399) (265) -
Net Income Cont. Operations (1,996) (1,794) 40,290 (1,546)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,996) (1,794) 40,290 (1,546)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,996) (1,753) 40,290 (1,546)

Bio-Matrix Scientific Group, Inc. BMSN Recent News

Jun 11, 2014 Bio-Matrix Scientific Group Inc. Subsidiary Regen BioPharma Inc. Collaborates on Research Paper Analyzing the Use of Gene Silencing in Heart Transplants
May 13, 2014 Bio-Matrix Scientific Group, Inc. Sees 37% Increase In Share Price
May 12, 2014 Regen BioPharma, a Majority Owned Subsidiary of Bio-Matrix Scientific Group, Provides Update on HemaXellerate I(TM) IND for Treatment of Drug Resistant Aplastic Anemia


BMSN Bio-Matrix Scientific Group, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=BMSN&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BMSN/quote
Stock Chart http://www.otcmarkets.com/stock/BMSN/chart
Company Info http://www.otcmarkets.com/stock/BMSN/company-info
Recent News http://www.otcmarkets.com/stock/BMSN/news
Financials http://www.otcmarkets.com/stock/BMSN/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BMSN/filings
Short Sales http://www.otcmarkets.com/stock/BMSN/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BMSN/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BMSN/research
Summary http://finance.yahoo.com/q?s=BMSN
Historical Prices http://finance.yahoo.com/q/hp?s=BMSN+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BMSN
Basic Chart http://finance.yahoo.com/q/bc?s=BMSN+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BMSN+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BMSN+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BMSN+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BMSN+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BMSN+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BMSN+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BMSN+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BMSN+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BMSN+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BMSN
Balance Sheet http://finance.yahoo.com/q/bs?s=BMSN
Cash Flow http://finance.yahoo.com/q/cf?s=BMSN+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BMSN
Market Watch http://www.marketwatch.com/investing/stock/BMSN
Bloomberg http://www.bloomberg.com/quote/BMSN:US
Morningstar http://quotes.morningstar.com/stock/s?t=BMSN
Bussinessweek http://investing.businessweek.com/research/st...icker=BMSN
Barchart http://www.barchart.com/quotes/stocks/BMSN
OTC Short Report http://otcshortreport.com/index.php?index=BMSN
Investopedia http://www.investopedia.com/markets/stocks/BMSN/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 62

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 299

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 29

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 123

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 456

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading

Top 5 Most Recently Viewed Articles

Brazil Potash Secures $75 Million Equity Line for Growth

Updated Category News Views 167

Brazil Potash Secures Key Funding for Autazes Project Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE American: GRO), a prominent player in mineral development focused on potash mining, has recently finalized a significant agreement establishing an equity line of credit (ELOC) with Alumni Capital LP. This collaboration signals a crucial step in...

Continue Reading
AGCO Completes Major Strategic Shift Transforming Business Focus

Updated Category News Views 101

AGCO Completes Divestiture of Grain & Protein Business AGCO Corporation (NYSE: AGCO), a leading firm in agricultural machinery and precision ag technology, has finalized the sale of the majority of its Grain & Protein business to American Industrial Partners (AIP) in an all-cash deal valued at around $700 million. This significant transition emphasizes AGCO's focus on...

Continue Reading
Vincent Bouatou Takes the Helm as CTO at IDEMIA Public Security

Updated Category News Views 64

Vincent Bouatou Appointed as Chief Technology Officer With a wealth of experience in the technology sector, Vincent Bouatou has been officially announced as the Chief Technology Officer (CTO) of IDEMIA Public Security. His extensive background in driving technological innovations positions him to make significant strides in the biometric technology industry. Driving...

Continue Reading
MedX Holdings, Inc. Reaches New Heights in Q1 Revenue Growth

Updated Category News Views 171

MedX Holdings, Inc. Reports Extraordinary Q1 Revenue Gains MedX Holdings, Inc. (OTC: MEDH) is delighted to share its impressive financial results for the first quarter of 2025. With record revenue levels and strategic advancements, this milestone reflects the company's commitment to becoming a prominent player in cannabis retail, technology, and franchise development....

Continue Reading
Erste Group Upgrades WW Grainger Stock Amid Positive Outlook

Updated Category News Views 74

Erste Group upgraded WW Grainger (NYSE: GWW) from Hold to Buy back in mid-2024, showing that the desks had a new favorite. With a return on equity at a whopping 59%, Grainger's performance left many competitors in the dust, making it a must-watch stock for anyone looking to get into industrial supply chains. What's Driving the Upgrade? The reasons behind this rating shift...

Continue Reading